Baird Financial Group, Inc. - VISTAGEN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$32,000
+113.3%
36,474
+197.4%
0.00%
Q1 2022$15,00012,2630.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Performa Ltd (US), LLC 4,900$9,1630.01%
View complete list of VISTAGEN THERAPEUTICS INC shareholders